Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
BrainsWay Ltd.

BrainsWay Ltd. (BWAY) Stock Overview

Explore BrainsWay Ltd.’s financial performance, market position, analyst ratings, and future outlook.

BWAY●NASDAQ
HealthcareMedical - Specialties
$13.91
$0.50(3.47%)
U.S. Market opens in 12h 51m

BrainsWay Ltd. (BWAY)

Meyka AI Score

Z

Key Financials

Market Cap545.6M
P/E Ratio30.56
EPS (TTM)$0.39
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$13.78
3 Months$16.81
1 Year Target$21.36

BWAY Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of BrainsWay Ltd. (NASDAQ: BWAY) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, BrainsWay Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BWAY on the NASDAQ shows an RSI of 41.52, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $21.36 for the NASDAQ listing.

Key metrics behind BrainsWay Ltd.'s NASDAQ-traded stock include a P/E ratio of 30.56 and a market capitalization of 545.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BWAY on the NASDAQ.

Price Performance (NASDAQ: BWAY)

1-Day Change
-3.47%
5-Day Change
-4.40%
1-Month Change
-9.20%
3-Month Change
-1.70%
6-Month Change
9.44%
Year-to-Date (YTD) Change
46.27%
1-Year Change
74.53%
3-Year Change
685.88%
5-Year Change
245.16%
All-Time (Max) Change
150.63%

Contact Information

https://www.brainsway.com
972 2 582 4030
16 Hartum St, Jerusalem, JM, 9777516

Company Facts

1,290 Employees
IPO DateApr 17, 2019
CountryIL
Actively Trading

Frequently Asked Questions